CLINICAL_TRIALS
trial_result
· 2013-06-17
Clinical Trial Update: Atomoxetine for Treatment of Weight Gain in Olanzapine or Clozapine Patients [Phase 4]
Summary
Phase 4 clinical trial update evaluating atomoxetine for weight gain in patients using olanzapine or clozapine for schizophrenia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Maryland, Baltimore | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED | Results posted: 2013-06-17